ArticleDose-response : a publication of International Hormesis Society

Paclitaxel, Carboplatin, and Bevacizumab in Advanced Cervical Cancer: A Treatment Response and Safety Analysis.

Wanjun Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.